| Radical Concurrent Chemoradiotherapy With DDP/5-FU and PD-1 Antibody for Non-metastatic Rectal Squamous Cell Carcinoma (NCT06364384) | Sixth Affiliated Hospital, Sun Yat-sen University | 2024-04-12 |
| Testing the Addition of an Investigational Drug, Xevinapant, to Usual Radiation Therapy Plus Cisplatin/Carboplatin for Patients With Head and Neck Cancer (NCT06084845) | ECOG-ACRIN Cancer Research Group | 2024-04-12 |
| A Clinical Study Evaluating the Safety, Tolerability, Pharmacokinetic Characteristics, and Preliminary Efficacy of the Combination of BAT8008 With BAT1308 in Patients With Advanced Solid Tumors (NCT06341114) | Bio-Thera Solutions | 2024-04-12 |
| A Study of TAE+HAIC Combined With Camrelizumab and Apatinib in the Treatment of Advanced Hepatocellular Carcinoma (NCT06363825) | Fujian Medical University | 2024-04-12 |
| Preventive Strategies for Early and Late Complications of Leptospirosis (NCT07127718) | National Kidney and Transplant Institute, Philippines | 2024-04-12 |
| Effect of 10 mg Xanamem on Dementia Due to Alzheimer's Disease (NCT06125951) | Actinogen Medical | 2024-04-12 |
| Vosoritide for Short Stature in Turner Syndrome (NCT05849389) | Roopa Kanakatti Shankar, MBBS, MS | 2024-04-12 |
| A Study of Barzolvolimab in Patients With Prurigo Nodularis (NCT06366750) | Celldex Therapeutics | 2024-04-12 |
| Randomized Study Versus Placebo for the Prevention of Neurotoxicity Induced by Weekly PACLITAXEL (NCT05695313) | Centre Georges Francois Leclerc | 2024-04-12 |
| VMAC+DLI Treatment of Patients With Relapse of AML After Allo-HSCT (NCT06447090) | Institute of Hematology & Blood Diseases Hospital, China | 2024-04-12 |
| Personalized Nutrition to Improve Recovery in Trauma (NCT06065202) | Duke University | 2024-04-12 |
| Identifying Findings on Brain Scans That Could Help Make Better Predictions About Brain Cancer Progression, The GABLE Trial (NCT06319027) | ECOG-ACRIN Cancer Research Group | 2024-04-11 |
| The Effect of Repetitive Transcranial Magnetic Stimulation on Cognitive Improvement in Dementia With Lewy Bodies (NCT07122908) | Korea University Anam Hospital | 2024-04-11 |
| Preoperative Immunotherapy Combined With Stereotactic Radiation Therapy Boost in the Treatment of HER2-negative Breast Cancer (NCT06472583) | Maria Sklodowska-Curie National Research Institute of Oncology | 2024-04-11 |
| A Study Of TL-925 For The Treatment of AC (NCT06293820) | Telios Pharma, Inc. | 2024-04-11 |
| REGN5381 in Adult Participants With Heart Failure With Reduced Ejection Fraction (NCT06237309) | Regeneron Pharmaceuticals | 2024-04-11 |
| Phase II Trial of ART + Dual bNAbs vs. ART + Placebo During Primary HIV-1 Infection-impact on Post-ART Control (NCT05300035) | ANRS, Emerging Infectious Diseases | 2024-04-11 |
| A Study of EDG-7500 in Adults With Hypertrophic Cardiomyopathy (CIRRUS-HCM) (NCT06347159) | Edgewise Therapeutics, Inc. | 2024-04-11 |
| Adebrelimab ±Induction Chemotherapy Followed by Concurrent Chemoradiotherapy for Unresectable Locally Advanced ESCC (NCT06510660) | Fujian Medical University Union Hospital | 2024-04-11 |
| FID-007 and Cetuximab in Treating Patients With Advanced Head and Neck Squamous Cell Carcinoma (NCT06332092) | Fulgent Pharma LLC. | 2024-04-10 |
| Effect of Pentoxifylline on Cognitive Impairment After Ischemic Stroke (NCT06344390) | The First Hospital of Hebei Medical University | 2024-04-10 |
| AK104 in Combination With AK112 Plus Chemotherapy(SOX/XELOX) as First-line Treatment for Advanced G/GEJ Cancer (NCT06196697) | Harbin Medical University | 2024-04-10 |
| A Study of BB-1701 in Previously Treated Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive or HER2-low Unresectable or Metastatic Breast Cancer (NCT06188559) | Eisai Inc. | 2024-04-10 |
| A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02) (NCT06330064) | Daiichi Sankyo | 2024-04-10 |
| Protective VEGF Inhibition for Isotoxic Dose Escalation in Glioblastoma (NCT05871021) | University Hospital Tuebingen | 2024-04-10 |
| Treatment Response Adapted Hybrid Radiotherapy in Metastatic Non-small Cell Lung Cancer Receiving First-line Immunotherapy (NCT06313541) | Fudan University | 2024-04-10 |
| Efficacy and Safety of TenoMiR in Lateral Epicondylitis (NCT06192927) | Causeway Therapeutics | 2024-04-10 |
| Study to Evaluate Adverse Events, Optimal Dose, and Change in Disease Activity, With Livmoniplimab in Combination With Budigalimab Plus Chemotherapy Versus IV Infused Pembrolizumab Plus Chemotherapy in Adult Participants With Untreated Metastatic Non-Squamous Non-Small Cell Lung Cancer (NSCLC) (NCT06236438) | AbbVie | 2024-04-10 |
| A Study of Adjuvant Intismeran Autogene (V940) and Pembrolizumab in Renal Cell Carcinoma (V940-004). (NCT06307431) | Merck Sharp & Dohme LLC | 2024-04-10 |
| Venetoclax Treatment (26 Cycles) With 6 Cycles or 12 Cycles of Epcoritamab in Patients With Relapsed or Refractory CLL or SLL (NCT05791409) | Stichting Hemato-Oncologie voor Volwassenen Nederland | 2024-04-10 |
| Paracetamol-Tramadol and Paracetamol-caffeine Versus Placebo in the Emergency Discharge Treatment of Renal Colic (NCT06345716) | University of Monastir | 2024-04-10 |
| Inositol in Letrozol Resistant PCOS Women (NCT07585396) | Kafrelsheikh University | 2024-04-10 |
| Developing ctDNA Guided Adjuvant Therapy for Gastrooesophageal Cancer (NCT05965479) | University of Southampton | 2024-04-10 |
| Tirofiban After Successful MT Recanalization in AIS (NCT06265051) | Xiang Luo | 2024-04-09 |
| Optimizing the Dose of Flucytosine for the Treatment of Cryptococcal Meningitis (NCT06414512) | University of Minnesota | 2024-04-09 |
| BAT1308 in Combination With Platinum-containing Chemotherapy is Used for the First-line Treatment of Advanced or Recurrent dMMR Endometrial Cancer (NCT06321068) | Bio-Thera Solutions | 2024-04-09 |
| Efficacy and Safety of Fecal Microbiota Transplantation (FMT) in Reducing Recurrence of Colorectal Adenoma (CRA) (NCT06205862) | Shenzhen Hospital of Southern Medical University | 2024-04-09 |
| To Assess the Safety and Efficacy of SP-002 with Vismodegib for the Treatment of Locally Advanced Basal Cell Carcinoma (NCT06344052) | Stamford Pharmaceuticals, Inc. | 2024-04-09 |
| Assessment of Volume-targeted Ventilation in Patients With Neuromuscular Disease (NCT06339580) | Guy's and St Thomas' NHS Foundation Trust | 2024-04-09 |
| Osimertinib Plus Dalpiciclib in Patients With EGFR-mutant, CDK4/6 Pathway Aberrant, Advanced Non-small Cell Lung Cancer Following Acquired Resistance to Third-generation EGFR TKI: a Phase II Trial (NCT06363734) | Tianjin Medical University Cancer Institute and Hospital | 2024-04-09 |
| Ensitrelvir for Viral Persistence and Inflammation in People Experiencing Long COVID (NCT06161688) | Timothy Henrich | 2024-04-09 |
| Smart Walk: A Culturally Tailored Smartphone-Delivered Physical Activity Intervention for African American Women (NCT06337708) | Arizona State University | 2024-04-08 |
| Disitamab Vedotin in the Treatment With HER2- Expression, Subjects With Locally Advanced or Metastatic Castration-resistant Prostate Cancer (NCT06227156) | RemeGen Co., Ltd. | 2024-04-08 |
| Cannabidiol as an add-on Treatment During Inpatient Alcohol Cessation : CBD-OH (NCT05860699) | Assistance Publique - Hôpitaux de Paris | 2024-04-08 |
| Phase 2a Study of DaxibotulinumtoxinA-lanm for Injection in Dynamic Forehead Lines and Glabellar Lines (NCT06411002) | Revance Therapeutics, Inc. | 2024-04-08 |
| Effects of Novel Estrogens on Glucose and Lipids in Postmenopausal Prediabetic Women Veterans (NCT05073237) | VA Office of Research and Development | 2024-04-08 |
| Dose Escalation Using Hypoxia-adjusted Radiotherapy (NCT06087614) | Rajiv Gandhi Cancer Institute & Research Center, India | 2024-04-08 |
| FOOD PRESCRIPTION APP (NCT05562180) | Kaiser Permanente | 2024-04-08 |
| A Study of IBI363 in Subjects with Advanced Solid Malignancies (NCT06281678) | Innovent Biologics (Suzhou) Co. Ltd. | 2024-04-08 |
| Haemodynamic Effects of Dobutamine in Patients With Wild-type Transthyretin Amyloid Cardiomyopathy (ATTRwt) (NCT06318260) | Steen Hvitfeldt Poulsen | 2024-04-08 |
| Edaravone Dexborneol Sublingual Tablet for the PSCI in Acute Ischemic Stroke Patients (NCT06315231) | Simcere Pharmaceutical Co., Ltd | 2024-04-08 |
| A Study to Evaluate the Efficacy and Safety of ZYIL1 Oral Capsules for the Treatment of Patients With Mild to Moderately Active Ulcerative Colitis Resistant or Intolerant to Oral Aminosalicylates (NCT06398808) | Zydus Lifesciences Limited | 2024-04-08 |
| Improvement of Quality of Life by Cannabinoids in Oncologic Patients (NCT06097533) | University Hospital Schleswig-Holstein | 2024-04-08 |
| Bicalutamide and Abemaciclib in Inoperable or Metastatic Androgen Receptor-positive Triple-negative Breast Cancer (NCT06365788) | Universitaire Ziekenhuizen KU Leuven | 2024-04-08 |
| Venetoclax Plus Azacitidine Versus Intensive Chemotherapy for Fit Patients With Newly Diagnosed NPM1 Mutated AML (NCT05904106) | Technische Universität Dresden | 2024-04-07 |
| IIT2023-09-Chung-UpfrontTAD: Upfront TAD/SNB in Patients With Breast Cancer With Nodal Metastases (NCT06092892) | Alice Chung | 2024-04-07 |
| [18F]FES PET/.CT in Uterine Cancer (NCT05916196) | Abramson Cancer Center at Penn Medicine | 2024-04-05 |
| Safety and Efficacy of Novel Combination Regimens for Treatment of Onchocerciasis (NCT06070116) | Washington University School of Medicine | 2024-04-05 |
| Study to Evaluate Safety, Efficacy and Immunogenicity of Acne mRNA Vaccine in Adults With Moderate to Severe Acne (NCT06316297) | Sanofi Pasteur, a Sanofi Company | 2024-04-05 |
| Β-Thalassemia Treatment with KL003 Cell Injection (NCT06280378) | Kanglin Biotechnology (Hangzhou) Co., Ltd. | 2024-04-05 |
| Trial of Semaglutide for Diabetic Kidney Disease in Type 1 Diabetes (NCT05822609) | University of Washington | 2024-04-05 |
| Combination of SBRT and Immunotherapy in Small Hepatocellular Carcinoma (HSBRT2402) (NCT06313190) | Sun Yat-sen University | 2024-04-05 |
| A Study to Test How Well BI 1291583 is Tolerated by People With Cystic Fibrosis Bronchiectasis (Clairafly™) (NCT05865886) | Boehringer Ingelheim | 2024-04-05 |
| Ultrasonic Neuromodulation for Treatment of PTSD (NCT06135064) | University of Utah | 2024-04-05 |
| "neoBREASTIM": Atezolizumab Plus RP1 Oncolytic Immunotherapy in the NeoAdjuvant Setting of Triple-Negative Breast Cancer (NCT06067061) | Institut Curie | 2024-04-05 |
| Efficacy of N-acetylcysteine in Preventing Radiotherapy-Induced Oral Mucositis in Head and Neck Cancer Patients. (NCT06354712) | Mansoura University | 2024-04-04 |
| An Evaluation of the Safety and Efficacy of Methylone for the Treatment of PTSD (NCT06215261) | Transcend Therapeutics | 2024-04-04 |
| Study of Lutetium (177Lu) Vipivotide Tetraxetan in mCRPC Participants With Moderately and Severely Impaired and With Normal Renal Function (NCT06004661) | Novartis Pharmaceuticals | 2024-04-04 |
| Serplulimab Combined With CCRT for LS-SCLC. (NCT06295926) | Peking Union Medical College Hospital | 2024-04-04 |
| Checkpoint Inhibitor Combinations Therapy as First Line for Inoperable Lung Cancer Via IT (NCT06483347) | Second Affiliated Hospital of Guangzhou Medical University | 2024-04-04 |
| A Study to Investigate the Efficacy of Durvalumab Plus Tremelimumab in Combination With Chemotherapy Compared With Pembrolizumab in Combination With Chemotherapy in Metastatic NSCLC Patients With Non-squamous Histology Who Have Mutations and/or Co-mutations in STK11, KEAP1, or KRAS (NCT06008093) | AstraZeneca | 2024-04-04 |
| Immunogenicity and Safety of Hecolin® in HIV Positive/Negative Adults and in Children (NCT06306196) | International Vaccine Institute | 2024-04-04 |
| Evaluation of Treatment Efficacy According to Risk Group in Relapsed Childhood Acute Lymphoblastic Leukemia (NCT05827549) | Ho Joon Im | 2024-04-04 |
| An International, Multicenter, Randomized, Double-Blind, Parallel Group, Vehicle-Controlled, Phase 2/3 Study With Open-Label Extension Evaluating the Efficacy and Safety of Diacerein 1% Ointment for the Treatment of Generalized Epidermolysis Bullosa Simplex (EBS) (NCT06073132) | TWi Biotechnology, Inc. | 2024-04-04 |
| A Study to Evaluate the Efficacy and Safety of GSK3915393 in Participants With Idiopathic Pulmonary Fibrosis (IPF) (NCT06317285) | GlaxoSmithKline | 2024-04-04 |
| Open Label Trial of Oral Letermovir for CMV Prophylaxis in Thoracic Transplant Recipients (NCT06066957) | University of Pennsylvania | 2024-04-04 |
| Evaluation of Efficacy, Safety and Molecular Mechanism of Pentoxifylline Supplementation in Patients With Hepatic and Obstructive Jaundice (NCT06944704) | Tanta University | 2024-04-03 |
| Pilot Window of Opportunity Trial (POET) (NCT06129604) | University of Oklahoma | 2024-04-03 |
| A Study Evaluating the Safety and Efficacy of Inhaled AP01 in Participants With Progressive Pulmonary Fibrosis (NCT06329401) | Avalyn Pharma Inc. | 2024-04-03 |
| A Study to Assess IPN01194 When Administered Alone in Adults With Advanced Solid Tumours (NCT06305247) | Ipsen | 2024-04-03 |
| SURVEILLE-HPV: Evaluation of HPV16 Circulating DNA as Biomarker to Detect the Recurrence, in Order to Improve Post Therapeutic Surveillance of HPV16-driven Oropharyngeal Cancers (NCT05582122) | UNICANCER | 2024-04-03 |
| A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression (NCT06051695) | A2 Biotherapeutics Inc. | 2024-04-03 |
| Testing MitoQ on Lower Urinary Tract Symptoms in Older Women With Metabolic Syndrome (NCT06351683) | Iman Al-Naggar, PhD | 2024-04-03 |
| Toripalimab Combined With Chidamide for the Treatment of Relapsed/Refractory Peripheral T-Cell Lymphoma (NCT06492629) | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2024-04-03 |
| A Trial Evaluating Omission of Radiotherapy to Regional Lymphatic's (NCT07528495) | All India Institute of Medical Sciences | 2024-04-03 |
| Intraoperative Dexmedetomidine and Coronary Artery Bypass Graft Surgery (NCT06378827) | University of Novi Sad | 2024-04-03 |
| Sickle Cell Disease Transplant Using a Nonmyeloablative Approach for Patients With Anti-donor Red Cell Antibody (NCT06358638) | Children's National Research Institute | 2024-04-03 |
| Effectivity of Allogenic Umbilical Cord Mesenchymal Stem Cells Conditioned Media for Osteoarthritis of the Knee Joint (NCT06688318) | Kementerian Riset dan Teknologi / Badan Riset dan Inovasi Nasional, Indonesia | 2024-04-03 |
| Unravelling Intestinal Fibrosis in Ulcerative Colitis (NCT06604273) | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 2024-04-03 |
| Safety, Tolerability and Efficacy of NPI-001 in Patients With Hereditary Cystatin C Amyloid Angiopathy (HCCAA) (NCT07716865) | Arctic Therapeutics | 2024-04-03 |
| Proton-Spatially Fractionated Radiotherapy and Standard Radiation Therapy for the Treatment of Newly Diagnosed Retroperitoneal Soft Tissue Sarcoma (NCT06327477) | Northwestern University | 2024-04-02 |
| Gemcitabine and Ex Vivo Expanded Allogenic Universal Donor, TGFβi Natural Killer (NK) Cells With or Without Naxitamab (Danyelza) for the Treatment of Patients With Metastatic, GD2 Expressing, HER2 Negative Breast Cancer (NCT06026657) | Margaret Gatti-Mays | 2024-04-02 |
| Reduced Intensive Idarubicin and Cytarabine Plus Venetoclax as First-line Treatment for Adults AML and MDS (NCT06050941) | First Affiliated Hospital of Zhejiang University | 2024-04-02 |
| Local Anesthesia for Facial Fractures (NCT06429501) | Washington University School of Medicine | 2024-04-02 |
| A Phase 2b Study to Evaluate Rezpegaldesleukin (Rezpeg) in the Treatment of Severe to Very Severe Alopecia Areata in Adult Patients (Rezolve AA) (NCT06340360) | Nektar Therapeutics | 2024-04-02 |
| PSMA-Guided Ablation of the Prostate (NCT06003556) | University of Alberta | 2024-04-02 |
| the Prevention of Bone Marrow Suppression Caused by Chemotherapy in Advanced NSCLC With Trilaciclib (NCT06370416) | Henan Cancer Hospital | 2024-04-02 |
| Azithromycin for Critical Asthma - Pediatrics (NCT06223828) | Johns Hopkins All Children's Hospital | 2024-04-02 |
| RRx-001 for Reducing Oral Mucositis in Patients Receiving Chemotherapy and Radiation for Head and Neck Cancer (NCT05966194) | EpicentRx, Inc. | 2024-04-02 |
| Study of a Respiratory Syncytial Virus Candidate Formulation in Adults Aged 60 Years and Older (NCT06251024) | Sanofi Pasteur, a Sanofi Company | 2024-04-02 |